Clinical Trial Update: Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of Naltrexone SR and Fluoxetine for obsessive-compulsive disorder was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Fluoxetine (Fluoxetine)
• Naltrexone SR (Naltrexone)

Snippet

Sponsor: Orexigen Therapeutics, Inc | Conditions: Obsessive-Compulsive Disorder | Phase 2 | Status: TERMINATED